Aspirin resistance in patients with ischemic stroke

INTRODUCTION[|]Aspirin is the basic agent of antithrombotic treatment in ischemic cerebrovascular disease (CVD) patients. However several patients don't respond to treatment and therefore aspirin resistance term has been used lately. Recent studies have shown that aspirin resistance incidence i...

Full description

Bibliographic Details
Main Authors: Anıl Bulut, Sultan Çağırıcı, Vildan Yayla, Murat Çabalar, Songül Şenadım
Format: Article
Language:English
Published: KARE Publishing 2019-01-01
Series:Southern Clinics of Istanbul Eurasia
Subjects:
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=scie&un=SCIE-40427
_version_ 1797920816887758848
author Anıl Bulut
Sultan Çağırıcı
Vildan Yayla
Murat Çabalar
Songül Şenadım
author_facet Anıl Bulut
Sultan Çağırıcı
Vildan Yayla
Murat Çabalar
Songül Şenadım
author_sort Anıl Bulut
collection DOAJ
description INTRODUCTION[|]Aspirin is the basic agent of antithrombotic treatment in ischemic cerebrovascular disease (CVD) patients. However several patients don't respond to treatment and therefore aspirin resistance term has been used lately. Recent studies have shown that aspirin resistance incidence is between 3-85% among CVD patients. In this study, we aimed to determine the frequency of aspirin resistance in CVD and their relationship with demographic characteristics, risk factors, and stroke subtypes were evaluated. [¤]METHODS[|]In a 6 months period 163 (106 Male-57 Female) acute ischemic stroke patients followed-up and treated with aspirin (100mg-300mg daily) were evaluated. Aspirin resistance was measured by a Multiplate® platelet analyser. Correlation between aspirin resistance and stroke subtypes, age, sex, weight, height, hypertension (HT), diabetes mellitus (DM), history of CVD, smoking, alcohol, hyperlipidemia (HL) and fasting blood glucose level were analyzed.[¤]RESULTS[|]Aspirin resistance was found in 16 male, 9 female, totally 25 (15.3%) of 163 patients. There was no statistically significant relationship between aspirin resistance and stroke-related clinical and laboratory parameters.[¤]DISCUSSION AND CONCLUSION[|]Our results needed to be confirmed with larger prospective trials in order to clarify which of the patients with ischemic stroke should be tested and how to treat the patients with resistance.[¤]
first_indexed 2024-04-10T14:06:54Z
format Article
id doaj.art-bc29c2f9ab334e2aaa8189d771d84b0f
institution Directory Open Access Journal
issn 2587-0998
language English
last_indexed 2024-04-10T14:06:54Z
publishDate 2019-01-01
publisher KARE Publishing
record_format Article
series Southern Clinics of Istanbul Eurasia
spelling doaj.art-bc29c2f9ab334e2aaa8189d771d84b0f2023-02-15T16:09:57ZengKARE PublishingSouthern Clinics of Istanbul Eurasia2587-09982019-01-0129422522910.14744/scie.2018.40427SCIE-40427Aspirin resistance in patients with ischemic strokeAnıl Bulut0Sultan Çağırıcı1Vildan Yayla2Murat Çabalar3Songül Şenadım4Department of Neurology, University of Health Sciences, Kartal Dr. Lütfi Kırdar Training and Research Hospital, Istanbul.Neurologist, Servergazi State Hospital, DenizliDepartment of Neurology, University of Health Sciences, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul.Department of Neurology, University of Health Sciences, Bakırköy Dr. Sadi Konuk Training and Research Hospital, Istanbul.Department of Neurology, University of Health Sciences, Bakırköy Prof. Dr. Mazhar Osman Mental Health and Disorders Training and Research Hospital, Istanbul.INTRODUCTION[|]Aspirin is the basic agent of antithrombotic treatment in ischemic cerebrovascular disease (CVD) patients. However several patients don't respond to treatment and therefore aspirin resistance term has been used lately. Recent studies have shown that aspirin resistance incidence is between 3-85% among CVD patients. In this study, we aimed to determine the frequency of aspirin resistance in CVD and their relationship with demographic characteristics, risk factors, and stroke subtypes were evaluated. [¤]METHODS[|]In a 6 months period 163 (106 Male-57 Female) acute ischemic stroke patients followed-up and treated with aspirin (100mg-300mg daily) were evaluated. Aspirin resistance was measured by a Multiplate® platelet analyser. Correlation between aspirin resistance and stroke subtypes, age, sex, weight, height, hypertension (HT), diabetes mellitus (DM), history of CVD, smoking, alcohol, hyperlipidemia (HL) and fasting blood glucose level were analyzed.[¤]RESULTS[|]Aspirin resistance was found in 16 male, 9 female, totally 25 (15.3%) of 163 patients. There was no statistically significant relationship between aspirin resistance and stroke-related clinical and laboratory parameters.[¤]DISCUSSION AND CONCLUSION[|]Our results needed to be confirmed with larger prospective trials in order to clarify which of the patients with ischemic stroke should be tested and how to treat the patients with resistance.[¤]https://jag.journalagent.com/z4/download_fulltext.asp?pdir=scie&un=SCIE-40427ischemic strokeaspirin resistancemultiplate analyzer
spellingShingle Anıl Bulut
Sultan Çağırıcı
Vildan Yayla
Murat Çabalar
Songül Şenadım
Aspirin resistance in patients with ischemic stroke
Southern Clinics of Istanbul Eurasia
ischemic stroke
aspirin resistance
multiplate analyzer
title Aspirin resistance in patients with ischemic stroke
title_full Aspirin resistance in patients with ischemic stroke
title_fullStr Aspirin resistance in patients with ischemic stroke
title_full_unstemmed Aspirin resistance in patients with ischemic stroke
title_short Aspirin resistance in patients with ischemic stroke
title_sort aspirin resistance in patients with ischemic stroke
topic ischemic stroke
aspirin resistance
multiplate analyzer
url https://jag.journalagent.com/z4/download_fulltext.asp?pdir=scie&un=SCIE-40427
work_keys_str_mv AT anılbulut aspirinresistanceinpatientswithischemicstroke
AT sultancagırıcı aspirinresistanceinpatientswithischemicstroke
AT vildanyayla aspirinresistanceinpatientswithischemicstroke
AT muratcabalar aspirinresistanceinpatientswithischemicstroke
AT songulsenadım aspirinresistanceinpatientswithischemicstroke